Lansoprazole Capsule, Delayed Release
Product Images NDC 50090-6079

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 50090-6079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-01 (F53ca2be A290 4157 Ad95 D24dfe3344f9 01)

Chemical structure of lansoprazole, a delayed-release oral capsule active ingredient, showing its molecular arrangement including a benzimidazole ring and substituted pyridine ring.*

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-02 (F53ca2be A290 4157 Ad95 D24dfe3344f9 02)

A line graph titled 'Mean Severity of Day Heartburn By Study Day For Evaluable Patients (3=Severe, 2=Moderate, 1=Mild, 0=None)' showing mean severity of day heartburn on the y-axis and days from start of treatment on the x-axis. The graph compares data for placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD over about 60 days.*

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-03 (F53ca2be A290 4157 Ad95 D24dfe3344f9 03)

A line graph showing the mean severity of night heartburn by study day for evaluable patients, comparing placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily over approximately 60 days from the start of treatment. Severity is rated from 0 (none) to 3 (severe).*

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-06 (F53ca2be A290 4157 Ad95 D24dfe3344f9 1)

Lansoprazole 15 mg delayed-release capsules in a blister pack. The packaging shows individual capsules arranged in rows with clear blister covering. The label includes the proprietary name Lansoprazole and identifies the product as oral capsules. The labeler is A-S Medication Solutions.*

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-07 (F53ca2be A290 4157 Ad95 D24dfe3344f9 2)

FDA Label Image

Label Image (Lbl500906079)

Lansoprazole 15 mg delayed-release capsules label by A-S Medication Solutions. The label indicates storage instructions at 77 degrees Fahrenheit and packaging details for 30 capsules. The product is identified with NDC 50090-6079 and is intended for oral use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.